These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

352 related items for PubMed ID: 15308385

  • 1. Endothelial dysfunction and hypertension in diabetes mellitus.
    Dandona P, Chaudhuri A, Aljada A.
    Med Clin North Am; 2004 Jul; 88(4):911-31, x-xi. PubMed ID: 15308385
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. [Anti-diabetic treatment, insulin resistance and cardiovascular disease in patients with type 2 diabetes].
    Hemmingsen B, Lund SS, Vaag A.
    Ugeskr Laeger; 2009 May 04; 171(19):1598-602. PubMed ID: 19419642
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Current pharmacotherapeutic concepts for the treatment of cardiovascular disease in diabetics.
    Highlander P, Shaw GP.
    Ther Adv Cardiovasc Dis; 2010 Feb 04; 4(1):43-54. PubMed ID: 19965897
    [Abstract] [Full Text] [Related]

  • 8. [Dangerous duo: hypertension and pre-diabetes--the underestimated risk].
    MMW Fortschr Med; 2003 Jan 23; 145(3-4):54-5. PubMed ID: 12619235
    [No Abstract] [Full Text] [Related]

  • 9. ESH-ESC guidelines for the management of hypertension.
    Erdine S, Ari O, Zanchetti A, Cifkova R, Fagard R, Kjeldsen S, Mancia G, Poulter N, Rahn KH, Rodicio JL, Ruilope LM, Staessen J, van Zwieten P, Waeber B, Williams B.
    Herz; 2006 Jun 23; 31(4):331-8. PubMed ID: 16810473
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Diabetic nephropathy in non-insulin dependent diabetes mellitus. Cardiovascular risk factors and antihypertensive treatment.
    Nielsen FS.
    Dan Med Bull; 2000 Sep 23; 47(4):249-70. PubMed ID: 11064829
    [No Abstract] [Full Text] [Related]

  • 12. Treatment of isolated systolic hypertension in diabetes mellitus type 2.
    Os I, Gudmundsdottir H, Kjeldsen SE, Oparil S.
    Diabetes Obes Metab; 2006 Jul 23; 8(4):381-7. PubMed ID: 16776744
    [Abstract] [Full Text] [Related]

  • 13. Potential cardiovascular benefits of insulin sensitizers.
    Kunhiraman BP, Jawa A, Fonseca VA.
    Endocrinol Metab Clin North Am; 2005 Mar 23; 34(1):117-35. PubMed ID: 15752925
    [Abstract] [Full Text] [Related]

  • 14. New onset diabetes during antihypertensive therapy.
    Alderman MH.
    Am J Hypertens; 2008 May 23; 21(5):493-9. PubMed ID: 18437139
    [Abstract] [Full Text] [Related]

  • 15. ADVANCE: action in diabetes and vascular disease.
    Patel A, Chalmers J, Poulter N.
    J Hum Hypertens; 2005 Jun 23; 19 Suppl 1():S27-32. PubMed ID: 16075030
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Endothelial function, insulin action and cardiovascular risk factors in young healthy adult offspring of parents with Type 2 diabetes: effect of vitamin E in a randomized double-blind, controlled clinical trial.
    McSorley PT, Bell PM, Young IS, Atkinson AB, Sheridan B, Fee JP, McCance DR.
    Diabet Med; 2005 Jun 23; 22(6):703-10. PubMed ID: 15910620
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 18.